SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950168-02-001902
Filing Date
2002-07-16
Accepted
2002-07-16 15:03:26
Documents
6
Period of Report
2002-07-15
Items
Item 2: Acquisition or disposition of assets
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 129686
3 SUBSIDIARIES dex21.htm EX-21 2358
4 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 5017
5 PRESS RELEASE dex991.htm EX-99.1 6733
6 FACTORS THAT MAY AFFECT AMGEN dex995.htm EX-99.5 63879
7 GRAPHIC g91730g07_45.jpg GRAPHIC 22318
  Complete submission text file 0000950168-02-001902.txt   232315
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 02703864
SIC: 2836 Biological Products, (No Diagnostic Substances)